The in vivo repopulation of hepatocytes depends on donor cell growth potential and recipient conditioning. We herein demonstrate the successful cell transplantation of a human hepatocyte cell line, THLE-5b, into the SCID mouse liver by means of a rather mild conditioning using a 55% hepatectomy and p21 transfection. Adult human liver-derived cells, THLE-5b, are SV40 T antigen-immortalized epithelial cells. A phenotypic examination of THLE-5b showed they expressed hepatic stem cell markers such as EpCAM, OCT3/4, and Thy-1, thus indicating the immature nature of the cells. A three-dimensional aggregate culture of THLE-5b showed a higher expression level of liver-specific genes such as albumin, α1-antitrypsin, and CYP3A4, thus suggesting that THLE-5b possess the capability to differentiate into hepatocytes. In a cell transplantation experiment, the cell cycle regulator p21 was transfected with adenoviral vector into the SCID mouse liver. On the next day, 8 × 10 5 cells of GFP-transfected THLE-5b were injected intrasplenically, together with the intraperitoneal administration of anti-asialo GM1 antibodies. The following day, a partial hepatectomy was performed. The GFP-THLE-5b cells were observed to have migrated and become integrated into the liver parenchyma 14 days after transplantation. The present protocol is thus considered to be a novel experimental model to elucidate the mechanism of hepatocyte repopulation and to develop efficient stem cell therapy in the liver. ) for providing cell aggregates, THLE-5b expressed AAT (Fig. 2B) . We sity of Tokyo, Japan) for providing adenoviral AxCALacZ. previously reported that the aggregated form of THLE-We also thank Mr. Kazuhito Sato for his excellent technical 5b showed a hepatocyte-like ultrastructure, ammonia assistance. This research was supported by Grant-in-aid metabolic activity, and several other indicators that sug-(KHD1023 and 1027) from the Japan Health Sciences Foungest hepatocytic maturation, including the upregulation dation, Tokyo, Japan. The authors declare no conflict of interest. or induction of liver-specific genes such as albumin and 452 ENOSAWA ET AL. Knisely, A. S.; Devereaux, S.; Richards, J.; Rela, M.;
INTRODUCTION
Clinically, there are two target disorders. One is the occurrence of congenital metabolic disorders and the other hepatic failure (2, 8, 9, 11) . The former diseases, Although some cases of clinical hepatocyte transplantation have been reported (2, 4, 11) , the therapeutic per-especially, single gene mutations such as ornithine transcarbamylase deficiency, Crigler-Najjar syndrome, gly-formance is not yet considered to be sufficient for organ transplantation and this treatment is recognized as being cogen storage disease, etc., will be a good indication of hepatocyte transplantation, because the host liver cells a bridge to liver transplantation. In experimental hepatocyte transplantation, preconditioning of the host liver are almost completely intact except for the responsible gene and the transplantation of cells that compensate for damage caused by hepatotoxins is indispensable for successfully inducing the repopulation of transplanted cells any defect is desired due to medical reasons rather than a whole liver replacement from an allogeneic donor. (1, 5, 6, 10, 12, 15, 17) . Otherwise, transplanted cells are normally quickly eliminated from the host liver, proba-However, the therapeutic outcome of hepatocyte transplantation is not equivalent (and not even semiequiva-bly due to inflammatory and immune responses. In addition, the damage of transplanted cells by the isolation lent) to liver transplantation. On the other hand, surgeons do not seem to be encouraged to try hepatocyte trans-and culture process will be another factor that makes it difficult to overcome the host response.
plantation for hepatic failure such as fulminant hepatic 448 ENOSAWA ET AL.
failure and liver cirrhosis, because there are fewer cases p21 Cip1 : sense 5′-ccaggaggcccgtgag-3′ and antisense 5′ggtaccacccagcggacaag-3′. reported than for metabolic disorders (2, 11) . Under those conditions, the host cells are damaged in a manner simi-p21 Cip1 Adenoviral Vector lar to that of experimental cell transplantation but the circumstances will be so severe, not only for the host A replication incompetent adenovirus, AxCAp21, which contains a chicken β-actin promoter with cyto-cells but also for any transplanted cells to survive. Therefore, a more feasible target of hepatocyte trans-megalovirus enhancer and the human p21 Cip1 gene was constructed as described by Terada et al. (13) . A replica-plantation will be congenital metabolic disorders, although the preconditioning of host liver damage is tion incompetent adenovirus containing the lacZ gene, AxCALacZ, generously provided by Dr. Saito (3) was clinically unacceptable.
The present report demonstrates a successful protocol used in the nontreatment control group. The viral preparations were purified using a cesium chloride density for hepatocyte transplantation using a hepatocyte progenitor-like cell line and cell cycle regulator. The proto-gradient and then were titrated with a plaque-forming assay on HEK293 cells. col is not applicable for clinical cell transplantation, but it is considered to help elucidate the mechanism of Reverse Transcription and Polymerase repopulation and efficient stem cell therapy.
Chain Reaction (RT-PCR) RT-PCR was performed according to the method MATERIALS AND METHODS described in previous reports (14, 16) . Briefly, total RNA Cell Line and Primary Human Hepatocytes was isolated by ISOGEN (Nippon Gene, Toyama, The human hepatocyte cell line, THLE-5b, was origi-Japan) and converted into double-stranded cDNA, using nally established from human primary hepatocytes by ReverTraAce-alpha Kit (Toyobo, Osaka, Japan). The the transfection of SV40 T antigen and it was kindly PCR program consisted of denaturation at 94°C for 1 provided by Dr. Harris (National Cancer Institute, min, annealing at 55°C for 1 min, and extension at 72°C Bethesda, MD, USA) (7) . The cells were maintained by for 2 min, and 25-40 cycles were applied. culturing in RPMI-1640 containing 10% fetal bovine serum and the cell split ratio at passage was 1:5. A sta-Cell Aggregate Formation and Immunohistochemistry ble transfectant of THLE-5b with green fluorescent pro-THLE-5b cells (5 × 10 5 ) in 3 ml of the medium were tein (GFP) was established by the lipofectamine cultured in a 25-ml Meyer's flask that was precoated transfection of the GFP gene and subsequent single cell with 2.5% poly(2-hydroxyethyl methacrylate) (P-3932, cloning. Human parenchymal hepatocytes as a source of Sigma, St. Louis, MO, USA) in ethanol to avoid cell mRNA were obtained from the HAB Research Organiadhesion to the wall. After incubating at 37°C, 5% CO 2 zation (Tokyo, Japan).
with continuous rotation at 70 rpm on an orbital shaker for 72 h, the formed aggregates were harvested for RT-Primers PCR or an immunohistochemical study. For immunohistochemistry, the samples were fixed first with acetone/ The primers used for reverse transcription and polymerase chain reaction (RT-PCR) were as follows.
methanol (1:1), followed by 10% neutralized formalin. The paraffin sections were stained with rabbit anti-Octamer binding transcription factor 4 (Oct-4): sense 5′gacaacaatgaaaatcttcaggaga-3′ and antisense 5′-ttctggcgc human AAT antibodies (Ylem SRL, Roma, Italy) and visualized with alkaline phosphatase-conjugated second-cggttacagaacca-3′; epithelial cell adhesion molecule (EpCAM): sense 5′-ctggccgtaaactgctttgt-3′ and antisense ary antibodies. 5′-agcccatcattgttctggag-3′; Thy-1: sense 5′-ctagtggacca Assessment of Liver Regeneration in SCID Mouse gagccttcg-3′ and antisense 5′-tggagtgcacacgtgtaggt-3′; c-kit: sense 5′gtgaatctacttggagcctg-3′ and antisense 5′-A male severe combined immunodeficient (SCID) mouse (CB17, 6-14 weeks old, specific pathogen-free tcattcttgatgtctctggc-3′; glucose-3-phosphate dehydrogenase (G3PDH): sense 5′-accacagtccatgccatcac-3′ and grade, CLEA Japan, Tokyo, Japan) was injected with adenoviral vector AxCAp21 (1 × 10 8 pfu in 1 ml saline) antisense 5′-tccaccaccctgttgctgta-3′; α1-antitrypsin (AAT): sense 5′-tcttctccacaccctcaacc-3′ and antisense 5′-cggtgt via tail vein and nontreated controls received the same dose of AxCALacZ. On the next day, the left lateral ctttgtcaagctca-3′; albumin: sense 5′-tgtgttgctgatgagtca gc-3′ and antisense 5′-tcagcagcaatgagacagag-3′; cyto-lobe of the liver was excised (55% partial hepatectomy). One hour before harvesting the liver, 100 mg/kg of bro-chrome P450 1A1 (CYP1A1): sense 5′-tcccctcttgaat gaaggtg-3′ and antisense 5′-atccgacagctggatattgg-3′; modeoxyuridine (BrdU, B-5002, Sigma) was injected intraperitoneally to label DNA synthesizing cells. The cytochrome p450 3A4 (CYP3A4): sense 5′-tcctcagcca gagagagagc-3′ and antisense 5′-ggctaccgtaagggtgttga-3′; liver sample was weighed and a portion of liver tissue was embedded in OTC compound (Sakura Seiki, Tokyo, Japan) and a section 4 µm thick was stained for BrdU immunohistochemically (BrdU Labeling and Detection Kit I, Roche Diagnostics, Mannheim, Germany). The ratio of stained cells to the total number of cells was determined by image analysis. The p21 expression in the liver was estimated by RT-PCR on days 0, 2, and 8.
THLE-5b Cell Transplantation Into SCID Mouse
The mouse was administered p21 adenoviral vector as described above 1 day before hepatocyte transplantation. GFP-transfected THLE-5b cells (8 × 10 5 in 0.1 ml saline) were injected intrasplenically together with the intraperitoneal administration of 100 µg of anti-asialo GM1 rabbit antibodies (Wako Pure Chemicals, Osaka, Japan) to inactivate natural killer cells. On the next day the left lateral lobe of the liver of removed (55% partial hepatectomy). The liver was excised 14 days after cell transplantation and embedded in OTC compound. Liver cryosections (4 µm thickness) were investigated using formed using the NIH Image software program from the National Institutes of Health. The value for each group was obtained from three independent experiments as a
The expression of albumin, CYP3A4, CYP1A1, and mean ± SD, and the value in each sample was the mean AAT mRNA, which are considered to be parenchymal of three separate areas. Statistical significance was hepatocyte markers, was upregulated under the aggregadetermined by one-way ANOVA and Fisher's PLSD tion culture of THLE-5b (Fig. 2) . The THLE-5b cells (Protected Least Significant Difference) test using the showed a fibroblast-like morphology under the monolayer StatView software program, version 5.0 for Macintosh culture ( Fig. 2A ). An immunocytochemical study of (SUS Institute, Cary, NC, USA).
THLE-5b showed AAT and albumin (albumin data not shown) to be stained only in the aggregates (Fig. 2A′, B) , Ethical and Regulatory Considerations thus suggesting that the cell character changed to mature Experimental procedures using human primary hepahepatocytes along with the aggregate formation. tocytes, experimental animals, and recombinant viral vectors were performed under permission of the institu-
The Retardation of Liver Regeneration After p21 tional review board, animal ethics committee, and exper-Transfection and THLE-5b Cell Transplantation imental recombinant DNA committee of National
The transfection of p21 obviously delayed liver Center for Child Health and Development (permission regeneration after a 55% partial hepatectomy (Fig. 3A) . numbers: 98, 00-001, 05-18).
The weight of the remnant liver of the p21 transfected mouse decreased significantly on day 6 after a hepatec-RESULTS tomy but survived thereafter. Since the hepatic paren-Phenotypic Properties of THLE-5b Cells chyma is a preferential site of adenoviral vector, the Under Monolayer and Aggregate Conditions expression of human p21 was clearly confirmed on days 2 and 8 by RT-PCR (Fig. 3A, inset) . The transfection The expression of the undifferentiated cell markers, EpCAM, OCT4, c-Kit, and Thy1, was more obviously also depressed cell proliferation after a hepatectomy (Fig. 3B) . In a mouse hepatectomy, the peak of the pro-prominent in the THLE-5b cells than in the hepatic parenchymal cells (Fig. 1) . In contrast, the expression of AAT liferating activity is around day 3, as shown in Figure  3B , whereas the peak in the rat is day 1 (preliminary and CYP3A4, the markers for well-differentiated parenchymal hepatocytes, was not very strong in these cells.
data). When the mice were transfected with p21, cell proliferation was clearly suppressed. In addition, the tryptophan 2,3-dioxygenase, and the downregulation of biliary cell markers such as γ-glutamyl transpeptidase p21-transfected mice that received a 70% hepatectomy (median and lateral lobes) died within 3 days (data not (14) . Transcription factors such as hepatocyte nuclear factor (HNF)-1 and HNF-4α were also upregulated or shown). Therefore, the cell transplantation experiment was performed by removing only the left lateral lobe induced. These results strongly indicated that THLE-5b should be considered a progenitor cell line. Recently, we (55% hepatectomy).
When the GFP stable transfectant of THLE-5b was detected side population cells in THLE-5b by a flow cytometry analysis after Hoechst 33342 staining (16). transplanted, only the p21-transfected hepatectomized mice accepted the cells. When transplanted into either Cell cycle regulator, p21 Clip1 clearly suppresses the cell cycle and its artificial expression sometimes makes the p21-transfected or hepatectomized mice, no cells survived (data not shown). The GFP-THLE-5b cells it possible to overcome proliferative inflammation (13). Its physiological function is effective across the species. were dispersed in hepatic parenchyma (Fig. 4A) . At higher magnification, some cells were observed to form Actually, we confirmed that the transfection of human p21 caused a decrease in the thymidine uptake of both a small cluster ( Fig. 4B) , thus suggesting the occurrence of cell division after integration in the tissue. rat and mouse primary hepatocytes with no sign of cell death (preliminary data). The use of p21 in combination with a 55% hepatectomy enabled the survival of trans-DISCUSSION planted cells under relatively milder conditions than the intoxication of carbon tetrachloride (1), retrorsine (6, 17) , THLE-5b cells are a relatively new cell line established from adult human hepatocytes, using SV40 T heterotopic expression of tissue plasminogen activator (12), and anti-Fas antibody (15). Indeed, the present pro-antigen. In spite of immortalization, THLE-5b cells are not tumorgenic (7) . Interestingly, these cells exhibit tocol itself is not yet recommended for the clinic, but this will be a useful experimental model for the develop-hepatic progenitor-like characteristics. Under monolayer culture conditions THLE-5b expressed undifferentiated ment of both cell transplantation and stem cell therapy. These results therefore imply that bipotent progenitor markers, such as EpCAM, OCT4, c-kit, and Thy-1 but not AAT and CYP3A4, which are the typical differentia-cell populations similar to THLE-5b cells may exist in the adult human liver. tion markers of parenchymal hepatocytes (Fig. 1) . The cells looked slightly like fibroblasts without expressing
